Table 2.
Twelve-year mortality and incidence data stratified by sex.
| TOTAL 6495 | FEMALES 2368 (36.5 %) | MALES 4127 (63.5 %) | Chi-square p-value | |
|---|---|---|---|---|
|
| ||||
| 12-year outcomes All-cause deaths* |
417 (6.4 %) | 98 (4.1 %) | 319 (7.7 %) | <0.001 |
| Lung cancer deaths | 103 (1.6 %) | 24 (1.0 %) | 79 (1.9 %) | 0.0052 |
| Other cancer deaths | 120 (1.9 %) | 32 (1.4 %) | 88 (2.15 %) | 0.0245 |
| CVD deaths | 73 (1.1 %) | 17 (0.7 %) | 56 (1.4 %) | 0.0187 |
| Other causes of deaths | 76 (1.2 %) | 15 (0.6 %) | 61 (1.5 %) | 0.0023 |
| Non-cancer deaths | 149 (2.3 %) |
32 (1.4 %) | 117 (2.8 %) | 0.001 |
| Non-CVD deaths | 299 (4.6 %) |
71 (3.0 %) | 228 (5.5 %) | <0.001 |
| Lung cancer incidence | 299 (4.6 %) |
105 (4.4 %) | 194 (4.7 %) | 0.62 |
| Proportion of stage I | 161 (53.9 %) | 61 (58.1 %) | 100 (51.2 %) | 0.27 |
Missing causes of deaths N = 45.